Global Radiopharmaceuticals in Nuclear Medicine Market Professional Survey Report 2017

November 2017 | 126 pages | ID: GDDE918B9C0WEN
QYResearch

Abstracts

This report studies Radiopharmaceuticals in Nuclear Medicine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Bracco Imaging S.P.A.
• Cambridge Isotope Laboratories, Inc.
• Cardinal Health, Inc.
• Covidien, Plc
• Eczacibasi-Monrol
• Fujifilm Holdings Corporation
• GE Healthcare (Subsidiary Of General Electric Company)
• IBA Group
• Isotec, Inc. (Sigma-Aldrich)
• Lantheus Medical Imaging, Inc.
• Nordion, Inc.
• Ntp Radioisotopes (Pty), Ltd.
• Siemens Healthcare (Subsidiary Of Siemens AG)
• Taiyo Nippon Sanso Corporation
• Urenco Limited
• Rotem Industries, Ltd., Inc.
• Australian Nuclear Association And Technology Organization (ANSTO)
• Board of Radiation And Isotope Technology (BRIT)
• Institute of Atomic Energy Polatom Radioisotope Centre
• Institute of Isotopes Co., Ltd.
• Institute Of Radioelement (IRE)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Diagnostic Radiopharmaceuticals
• Therapy Radiopharmaceuticals
• Enriched Stable Isotopes

By Application, the market can be split into

• Diagnostic Application
• Therapeutic Application
• Research
• Pharmaceutical
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Radiopharmaceuticals in Nuclear Medicine Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE

1.1 Definition and Specifications of Radiopharmaceuticals in Nuclear Medicine
  1.1.1 Definition of Radiopharmaceuticals in Nuclear Medicine
  1.1.2 Specifications of Radiopharmaceuticals in Nuclear Medicine
1.2 Classification of Radiopharmaceuticals in Nuclear Medicine
  1.2.1 Diagnostic Radiopharmaceuticals
  1.2.2 Therapy Radiopharmaceuticals
  1.2.3 Enriched Stable Isotopes
1.3 Applications of Radiopharmaceuticals in Nuclear Medicine
  1.3.1 Diagnostic Application
  1.3.2 Therapeutic Application
  1.3.3 Research
  1.3.4 Pharmaceutical
  1.3.5 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine
2.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
2.4 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE

3.1 Capacity and Commercial Production Date of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016

4 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate Analysis
  4.2.2 2016 Radiopharmaceuticals in Nuclear Medicine Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Analysis
  4.3.2 2016 Radiopharmaceuticals in Nuclear Medicine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Radiopharmaceuticals in Nuclear Medicine Sales Price
  4.4.2 2016 Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis (Company Segment)

5 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE REGIONAL MARKET ANALYSIS

5.1 North America Radiopharmaceuticals in Nuclear Medicine Market Analysis
  5.1.1 North America Radiopharmaceuticals in Nuclear Medicine Market Overview
  5.1.2 North America 2012-2017E Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
  5.1.4 North America 2016 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
5.2 China Radiopharmaceuticals in Nuclear Medicine Market Analysis
  5.2.1 China Radiopharmaceuticals in Nuclear Medicine Market Overview
  5.2.2 China 2012-2017E Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
  5.2.4 China 2016 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
5.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Analysis
  5.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Overview
  5.3.2 Europe 2012-2017E Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
  5.3.4 Europe 2016 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
5.4 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Analysis
  5.4.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Overview
  5.4.2 Southeast Asia 2012-2017E Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
  5.4.4 Southeast Asia 2016 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
5.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Analysis
  5.5.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Overview
  5.5.2 Japan 2012-2017E Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
  5.5.4 Japan 2016 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis
5.6 India Radiopharmaceuticals in Nuclear Medicine Market Analysis
  5.6.1 India Radiopharmaceuticals in Nuclear Medicine Market Overview
  5.6.2 India 2012-2017E Radiopharmaceuticals in Nuclear Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price Analysis
  5.6.4 India 2016 Radiopharmaceuticals in Nuclear Medicine Market Share Analysis

6 GLOBAL 2012-2017E RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales by Type
6.2 Different Types of Radiopharmaceuticals in Nuclear Medicine Product Interview Price Analysis
6.3 Different Types of Radiopharmaceuticals in Nuclear Medicine Product Driving Factors Analysis
  6.3.1 Diagnostic Radiopharmaceuticals of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
  6.3.2 Therapy Radiopharmaceuticals of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
  6.3.3 Enriched Stable Isotopes of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis

7 GLOBAL 2012-2017E RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Radiopharmaceuticals in Nuclear Medicine Consumption by Application
7.2 Different Application of Radiopharmaceuticals in Nuclear Medicine Product Interview Price Analysis
7.3 Different Application of Radiopharmaceuticals in Nuclear Medicine Product Driving Factors Analysis
  7.3.1 Diagnostic Application of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
  7.3.2 Therapeutic Application of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
  7.3.3 Research of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
  7.3.4 Pharmaceutical of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis
  7.3.5 Other of Radiopharmaceuticals in Nuclear Medicine Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE

8.1 Bracco Imaging S.P.A.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Bracco Imaging S.P.A. 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Bracco Imaging S.P.A. 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.2 Cambridge Isotope Laboratories, Inc.
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Cambridge Isotope Laboratories, Inc. 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Cambridge Isotope Laboratories, Inc. 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.3 Cardinal Health, Inc.
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Cardinal Health, Inc. 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Cardinal Health, Inc. 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.4 Covidien, Plc
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Covidien, Plc 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Covidien, Plc 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.5 Eczacibasi-Monrol
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Eczacibasi-Monrol 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Eczacibasi-Monrol 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.6 Fujifilm Holdings Corporation
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Fujifilm Holdings Corporation 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Fujifilm Holdings Corporation 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.7 GE Healthcare (Subsidiary Of General Electric Company)
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 GE Healthcare (Subsidiary Of General Electric Company) 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 GE Healthcare (Subsidiary Of General Electric Company) 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.8 IBA Group
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 IBA Group 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 IBA Group 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.9 Isotec, Inc. (Sigma-Aldrich)
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Isotec, Inc. (Sigma-Aldrich) 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Isotec, Inc. (Sigma-Aldrich) 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.10 Lantheus Medical Imaging, Inc.
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Lantheus Medical Imaging, Inc. 2016 Radiopharmaceuticals in Nuclear Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Lantheus Medical Imaging, Inc. 2016 Radiopharmaceuticals in Nuclear Medicine Business Region Distribution Analysis
8.11 Nordion, Inc.
8.12 Ntp Radioisotopes (Pty), Ltd.
8.13 Siemens Healthcare (Subsidiary Of Siemens AG)
8.14 Taiyo Nippon Sanso Corporation
8.15 Urenco Limited
8.16 Rotem Industries, Ltd., Inc.
8.17 Australian Nuclear Association And Technology Organization (ANSTO)
8.18 Board of Radiation And Isotope Technology (BRIT)
8.19 Institute of Atomic Energy Polatom Radioisotope Centre
8.20 Institute of Isotopes Co., Ltd.
8.21 Institute Of Radioelement (IRE)

9 DEVELOPMENT TREND OF ANALYSIS OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET

9.1 Global Radiopharmaceuticals in Nuclear Medicine Market Trend Analysis
  9.1.1 Global 2017-2022 Radiopharmaceuticals in Nuclear Medicine Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Radiopharmaceuticals in Nuclear Medicine Sales Price Forecast
9.2 Radiopharmaceuticals in Nuclear Medicine Regional Market Trend
  9.2.1 North America 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
  9.2.2 China 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
  9.2.3 Europe 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
  9.2.5 Japan 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
  9.2.6 India 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Forecast
9.3 Radiopharmaceuticals in Nuclear Medicine Market Trend (Product Type)
9.4 Radiopharmaceuticals in Nuclear Medicine Market Trend (Application)

10 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKETING TYPE ANALYSIS

10.1 Radiopharmaceuticals in Nuclear Medicine Regional Marketing Type Analysis
10.2 Radiopharmaceuticals in Nuclear Medicine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Radiopharmaceuticals in Nuclear Medicine by Region
10.4 Radiopharmaceuticals in Nuclear Medicine Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Radiopharmaceuticals in Nuclear Medicine
Table Product Specifications of Radiopharmaceuticals in Nuclear Medicine
Table Classification of Radiopharmaceuticals in Nuclear Medicine
Figure Global Production Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2016
Figure Diagnostic Radiopharmaceuticals Picture
Table Major Manufacturers of Diagnostic Radiopharmaceuticals
Figure Therapy Radiopharmaceuticals Picture
Table Major Manufacturers of Therapy Radiopharmaceuticals
Figure Enriched Stable Isotopes Picture
Table Major Manufacturers of Enriched Stable Isotopes
Table Applications of Radiopharmaceuticals in Nuclear Medicine
Figure Global Consumption Volume Market Share of Radiopharmaceuticals in Nuclear Medicine by Application in 2016
Figure Diagnostic Application Examples
Table Major Consumers in Diagnostic Application
Figure Therapeutic Application Examples
Table Major Consumers in Therapeutic Application
Figure Research Examples
Table Major Consumers in Research
Figure Pharmaceutical Examples
Table Major Consumers in Pharmaceutical
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Radiopharmaceuticals in Nuclear Medicine by Regions
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) (2012-2022)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) (2012-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) (2012-2022)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) (2012-2022)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) (2012-2022)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) (2012-2022)
Table Radiopharmaceuticals in Nuclear Medicine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine in 2016
Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Figure Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine
Table Capacity and Commercial Production Date of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Radiopharmaceuticals in Nuclear Medicine 2012-2017
Figure Global 2012-2017E Radiopharmaceuticals in Nuclear Medicine Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Radiopharmaceuticals in Nuclear Medicine Market Size (Value) and Growth Rate
Table 2012-2017E Global Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate
Table 2016 Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate
Table 2016 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) List (Company Segment)
Table 2012-2017E Global Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit)
Table 2016 Global Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Radiopharmaceuticals in Nuclear Medicine 2012-2017E
Figure North America 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit)
Figure North America 2016 Radiopharmaceuticals in Nuclear Medicine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Radiopharmaceuticals in Nuclear Medicine 2012-2017E
Figure China 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit)
Figure China 2016 Radiopharmaceuticals in Nuclear Medicine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Radiopharmaceuticals in Nuclear Medicine 2012-2017E
Figure Europe 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit)
Figure Europe 2016 Radiopharmaceuticals in Nuclear Medicine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Radiopharmaceuticals in Nuclear Medicine 2012-2017E
Figure Southeast Asia 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit)
Figure Southeast Asia 2016 Radiopharmaceuticals in Nuclear Medicine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Radiopharmaceuticals in Nuclear Medicine 2012-2017E
Figure Japan 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit)
Figure Japan 2016 Radiopharmaceuticals in Nuclear Medicine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Radiopharmaceuticals in Nuclear Medicine 2012-2017E
Figure India 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit)
Figure India 2016 Radiopharmaceuticals in Nuclear Medicine Sales Market Share
Table Global 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Type
Table Different Types Radiopharmaceuticals in Nuclear Medicine Product Interview Price
Table Global 2012-2017E Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Application
Table Different Application Radiopharmaceuticals in Nuclear Medicine Product Interview Price
Table Bracco Imaging S.P.A. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Cambridge Isotope Laboratories, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Cardinal Health, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2015 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Covidien, Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Eczacibasi-Monrol Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Fujifilm Holdings Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2016 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table GE Healthcare (Subsidiary Of General Electric Company) Information List
Table Product A Overview
Table Product B Overview
Table 2016 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table IBA Group Information List
Table Product A Overview
Table Product B Overview
Table 2016 IBA Group Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 IBA Group Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Isotec, Inc. (Sigma-Aldrich) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Lantheus Medical Imaging, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Business Region Distribution
Table Nordion, Inc. Information List
Table Ntp Radioisotopes (Pty), Ltd. Information List
Table Siemens Healthcare (Subsidiary Of Siemens AG) Information List
Table Taiyo Nippon Sanso Corporation Information List
Table Urenco Limited Information List
Table Rotem Industries, Ltd., Inc. Information List
Table Australian Nuclear Association And Technology Organization (ANSTO) Information List
Table Board of Radiation And Isotope Technology (BRIT) Information List
Table Institute of Atomic Energy Polatom Radioisotope Centre Information List
Table Institute of Isotopes Co., Ltd. Information List
Table Institute Of Radioelement (IRE) Information List
Figure Global 2017-2022 Radiopharmaceuticals in Nuclear Medicine Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Radiopharmaceuticals in Nuclear Medicine Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Radiopharmaceuticals in Nuclear Medicine by Type 2017-2022
Table Global Consumption Volume (K Units) of Radiopharmaceuticals in Nuclear Medicine by Application 2017-2022
Table Traders or Distributors with Contact Information of Radiopharmaceuticals in Nuclear Medicine by Region